Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Background: Malaria in Brazil represents one of the highest percentages of Latin America cases, where approximately 84% of infections are attributed to Plasmodium ( P . ) vivax . Despite the high incidence, many aspects of gestational malaria resulting from P . vivax infections remain poorly studied. As such, we aimed to evaluate the consequences of P . vivax infections during gestation on the health of mothers and their neonates in an endemic area of the Amazon. Methods and findings: We have conducted an observational cohort study in Brazilian Amazon between January 2013 and April 2015. 600 pregnant women were enrolled and followed until delivery. After applying exclusion criteria, 329 mother-child pairs were included in the analysis. Clinical data regarding maternal infection, newborn’s anthropometric measures, placental histopathological characteristics, and angiogenic and inflammatory factors were evaluated. The presence of plasma IgG against the P . vivax (Pv) MSP1 19 protein was used as marker of exposure and possible associations with pregnancy outcomes were analyzed. Multivariate logistic regression analysis revealed that P . vivax infections during the first trimester of pregnancy are associated with adverse gestational outcomes such as premature birth (adjusted odds ratio [aOR] 8.12, 95% confidence interval [95%CI] 2.69–24.54, p < 0.0001) and reduced head circumference (aOR 3.58, 95%CI 1.29–9.97, p = 0.01). Histopathology analysis showed marked differences between placentas from P . vivax -infected and non-infected pregnant women, especially regarding placental monocytes infiltrate. Placental levels of vasomodulatory factors such as angiopoietin-2 (ANG-2) and complement proteins such as C5a were also altered at delivery. Plasma levels of anti-PvMSP1 19 IgG in infected pregnant women were shown to be a reliable exposure marker; yet, with no association with improved pregnancy outcomes. Conclusions: This study indicates that P . vivax malaria during the first trimester of pregnancy represents a higher likelihood of subsequent poor pregnancy outcomes associated with marked placental histologic modification and angiogenic/inflammatory imbalance. Additionally, our findings support the idea that antibodies against PvMSP1 19 are not protective against poor pregnancy outcomes induced by P . vivax infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, a study conducted in Brazil by Dombrowski et al. (2021) found that IgG against the P.vivax MSP119 protein was used as a marker for exposure during pregnancy [96].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [96]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, a study conducted in Brazil by Dombrowski et al. (2021) found that IgG against the P.vivax MSP119 protein was used as a marker for exposure during pregnancy [96].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as Dombrowski et al. (2021)
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dombrowski et al. (2020) found that, in the Brazilian Amazon, plasma IgG against the MSP119 protein of P.vivax serves as a marker for infection during the first trimester of pregnancy [116].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [116]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“It is unclear whether placental vasomodulation is being promoted or inhibited in our cohort, as diminished sFlt-1 and increased sVEGFR-2 support angiogenesis and vasodilation [58], while decreased ANG-2 and increased sTIE-2 suggest an anti-angiogenic environment [59].”
BackgroundVillar, J., Ismail, L. C., Victora, C. G., Ohuma, E. O., Bertino, E., Altman, D. G., Lambert, A., Papageorghiou, A. T., Carvalho, M., Jaffer, Y. A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60932-6 · Cited by 2,281 · cited 1×
“Small for gestational age (SGA), reduced head circumference, and reduced body length were defined as: birth weight, head circumference and length below the 10th percentile sex-specific for GA according to the INTERGROWTH-21st standards [31].”
MethodLow birthweight: country regional and global estimates.
Wardlaw, T., Blanc, A. K., Zupan, J., & Åhman, A. (2004) · Cited by 1,773
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432 · cited 2×
“The burden of first trimester infections, was scarcely addressed by researchers until recent years [7] despite knowing that perturbation in early pregnancy imposes severe fetal development consequences [41,42].”
BackgroundAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Keeping It All Going—Complement Meets Metabolism
Kolev, M., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 812
The Impact of Placental Malaria on Gestational Age and Birth Weight
Menendez, C., Ordi, J., Ismail, M. R., Ventura, P. J., Aponte, J. J., Kahigwa, E., Font, F., & Alonso, P. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315449 · Cited by 467
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.760-769.2004 · Cited by 458
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381 · cited 2×
“vivax MiP outcomes is still inconclusive [16,35,36].”
BackgroundTracking placental development in health and disease
Aplin, J. D., Myers, J. E., Timms, K., & Westwood, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0372-6 · Cited by 374 · cited 1×
“The burden of first trimester infections, was scarcely addressed by researchers until recent years [7] despite knowing that perturbation in early pregnancy imposes severe fetal development consequences [41,42].”
Background
Research works printed but not linked: 2
- Brazil. Ministry of Health. Secretariat of Health Surveillance. Department of Epidemiological Surveillance. Malaria’s treatment in Brazil practical guide. Brazilian Ministry of Health, Departamento de Vigilância Epidemiológica—Secretaria de Vigilância em Saúde. Brasília/DF: Ministry of Health; 2010.
- WHO. Guidelines for the treatment of malaria - 3rd edition. Geneva: World Health Organization; 2015. 26020088
Cited by
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions
Walker, I. S., & Rogerson, S. J. (2023) · Virulence · doi:10.1080/21505594.2022.2150456 · Cited by 70
“pregnancy is less well studied but has also been associated with preterm birth and low birthweight [341,342].”
BackgroundCurrent update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
“Additionally, a study conducted in Brazil by Dombrowski et al. (2021) found that IgG against the P.vivax MSP 119 protein was used as a marker for exposure during pregnancy [96].”
The biology and pathogenesis of vivax malaria
Anstey, N. M., Tham, W., Shanks, G. D., Poespoprodjo, J. R., Russell, B., & Kho, S. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.04.015 · Cited by 38
Adverse pregnancy outcomes in maternal malarial infection: A systematic review and meta-analysis
Satapathy, P., Khatib, M. N., Gaidhane, S., Zahiruddin, Q. S., Sharma, R. K., Rustagi, S., Al-Jishi, J. M., Albayat, H., Fares, M. A. A., Garout, M. A., et al. (2024) · New Microbes and New Infections · doi:10.1016/j.nmni.2024.101474 · Cited by 41
“Studies were conducted in a variety of locations, including Uganda [28 – 30], Ethiopia [31,32], Brazil [33 – 35], Cameroon [19,36 – 38], Ghana [39,40], Gabon [41,42], India [43 – 46], Thailand [47,48], the Democratic Republic of the Congo [49], Zimbabwe [50,51], Malawi [52], Tanzania [53], Colombia…”
BackgroundNana, R. R. D., Hawadak, J., Foko, L. P. K., Kumar, A., Chaudhry, S., Arya, A., & Singh, V. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2128563 · Cited by 39
“3) Pv [46] Colombia 2014 – 2015 180 (25.”
Pregnancy and malaria: The perfect storm
Rogerson, S. J., & Unger, H. W. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000859 · Cited by 17
Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
Santos, Y. D. S., Gamon, T. H. M., de Azevedo, M. S. P., Telezynski, B. L., de Souza, E. E., Oliveira, D. B. L., Dombrowski, J. G., Rosa-Fernandes, L., Palmisano, G., Carvalho, L. J. M., et al. (2023) · Viruses · doi:10.3390/v15040999 · Cited by 18
Self-citationBogale, K. A., Azage, M., Gelaye, K. A., Muchie, K. F., Asemahagn, M. A., & Enbiale, W. (2025) · Malaria Journal · doi:10.1186/s12936-025-05555-8 · Cited by 13
“The absence of prophylaxis exacerbates maternal anemia and fetal growth restriction, compounding adverse pregnancy outcomes [62, 63].”
Kumar, R., Farzeen, M., Ahmed, J., Lal, M., & Somrongthong, R. (2021) · Malaria Journal · doi:10.1186/s12936-021-03878-w · Cited by 14
“falciparum or Plasmodium vivax are endemic [9, 10].”
Update on pathogenesis, management, and control of Plasmodium vivax
Khan, N., & Daily, J. P. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000867 · Cited by 14
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
Abla, N., Marrast, A. C., Jambert, E., Richardson, N., Duparc, S., Almond, L. M., Yeo, K. R., Pan, X., Tärning, J., Zhao, P., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-05112-9 · Cited by 9
Malaria in pregnancy at the frontline: a delicate balance
Kokuhennadige, V., Aitken, E. H., & Rogerson, S. J. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102726 · Cited by 8
Aung, P. P., Han, K. T., Groot, W., Biesma, R., Thein, Z. W., Htay, T., Lin, Z., Aye, K. H., Adams, M., & Pavlova, M. (2024) · Tropical Medicine and Health · doi:10.1186/s41182-024-00577-5 · Cited by 7
Complement System Activation Is a Plasma Biomarker Signature during Malaria in Pregnancy
Santiago, V. F., Dombrowski, J. G., Kawahara, R., Rosa-Fernandes, L., Mule, S. N., Murillo, O. J., Santana, T. V., Coutinho, J. V. P., Macedo-da-Silva, J., Lázari, L. C., et al. (2023) · Genes · doi:10.3390/genes14081624 · Cited by 8
“The reduced placental vascular space is hypothesized to be associated with lower blood flow in the placenta, resulting in decreased fetal viability and intrauterine growth restriction [29].”
BackgroundSelf-citationDombrowski, J. G., Acford-Palmer, H., Campos, M., Separovic, E. P. M., Epiphanio, S., Clark, T. G., Campino, S., & Marinho, C. R. F. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100407 · Cited by 5
Self-citationDombrowski, J. G., Gomes, L. C., Lorenz, C., Palasio, R. G. S., Marchesini, P. B., Epiphânio, S., & Marinho, C. R. F. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100285 · Cited by 7
Self-citationHiggins, M., Kristan, M., Collins, E. L., Messenger, L. A., Dombrowski, J. G., Vanheer, L. N., Nolder, D., DRAKELEY, C. J., Stone, W. J., Mahamar, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71129-4 · Cited by 5
“A total of 12 whole blood samples were selected from P. vivax carriers, aged between 13–30 years, recruited as part of a cohort study of pregnant women, performed in the State of Acre, Brazil, between 2013–2015 36 .”
BackgroundSelf-citationSeijas-Chávez, J. A., Nolan, M. S., Lynn, M. K., da Rocha, M. J. F., Araújo, M. D. C., Fonseca, F. L. A., & Laporta, G. Z. (2021) · Malaria Journal · doi:10.1186/s12936-021-03981-y · Cited by 4
da Silva, R. N., Pirkle, C. M., Sentell, T. L., Peltzer, N. K., Wu, Y. Y., Domingues, M. R., & da Câmara, S. M. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19073897 · Cited by 4
“Pregnancy imposes additional hemoglobin requirements [2,6], rendering pregnant adolescents vulnerable to anemia and adverse maternal and child health consequences, like intrauterine growth retardation [11] and low birth weight [6].”
Backgrounddos Santos, M. I., Dombrowski, J. G., Hoffmann-Veltung, H., Quintana, M. D. P., Marinho, C. R. F., Hviid, L., & Lopez-Perez, M. (2025) · Infection and Immunity · doi:10.1128/iai.00516-25 · Cited by 3
“The samples used here originated from a cohort/case-control study of malaria in pregnancy, conducted in the Juruá Valley region, Acre state, Brazil (25, 26).”
Self-citationMalaria asociada al embarazo: revisión narrativa
Núñez-Troconis, J., Ruiz, D. E. C., & Núñez, E. N. M. (2023) · Revista de Obstetricia y Ginecología de Venezuela · doi:10.51288/00830112 · Cited by 5
“…neonatal, inhibe su crecimiento adecuado, y puede desencadenar, en un futuro, retraso del desarrollo psicomotor en el neonato, siendo un factor de riesgo en el aumento de la mortalidad perinatal, neonatal e infantil (2, 14, 52); y pudiendo provocar enfermedades crónicas en la adultez (47).”
Influentialdos Santos, M. I., Carvalho, A. R., de Oliveira, G. M., Gomes, L. C., Syed, W. A. P., Separovic, E. P. M., Epiphânio, S., Wunderlich, G., Marinho, C. R. F., & Dombrowski, J. G. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005526 · Cited by 2
“Furthermore, these alterations also extend to P. vivax -infected women, with reduced placental plasma levels for Ang-2, sFLT1, and leptin, and higher levels of Tie2 [8].”
InfluentialSelf-citationTovar, C., Pineda, C. A. B., Vergara, E. D. P., Cornejo, N. D., & Ricardo-Caldera, D. (2025) · IJID Regions · doi:10.1016/j.ijregi.2025.100586 · Cited by 2
“In addition, low levels of antibodies against P. vivax provide insufficient protection against adverse pregnancy events [ 6 ].”
de Souza, R. M., dos Santos, M. I., Gomes, L. C., de Melo, B. B. P., Separovic, E. P. M., Murillo, O. J., Wunderlich, G., Clark, T. G., Campino, S. G., Epiphânio, S., et al. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012636 · Cited by 1
Self-citationGordillo-Franco, R., Ortiz, L., Bardají, A., Castañeda, D., Menéndez, C., Padilla, N., & Castellanos, M. E. (2025) · Malaria Journal · doi:10.1186/s12936-025-05670-6 · Cited by 1
“A study in Brazil found that infection with P. vivax was associated with placental lesions and an imbalance in homeostasis, as well as altered angiogenic factors, leptin, and cytokines [49].”
Batalha, F. D. A., da Silva, E. F., Serra, P. T., dos Santos, R. O., Salimo, Z. M., Chaves, Y. O., Fagundes, M. Í., Feuser, P. E., de Souza, V. C., Naveca, F. G., et al. (2024) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_35_24 · Cited by 1
Farias, E., Jordão, M. F., Machado‐de‐Ávila, R. A., Fagundes, M. Í., Feuser, P. E., de Souza, V. C., Naveca, F. G., & Nogueira, P. A. (2021) · Research Square · doi:10.21203/rs.3.rs-1160593/v1 · Cited by 1
Malaria and pregnancy: a Venezuelan approach. Review article
Ruiz, D. E. C., Núñez, E. N. M., Martín-Castelli, J. M., Arrizabalo-Seir, S. M., Gamboa, A. G. M., & Núñez-Troconis, J. (2022) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2022.13.00669
The silent threat of submicroscopic Plasmodium infections during pregnancy
Santi, S. M. D. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00249-8
Predictor of Adverse Pregnancy Outcome: A Scoping Review
Abdurrahman, E. S., Siregar, K. N., Rikawarastuti, R., & Nasir, N. M. (2023) · Advances in health sciences research/Advances in Health Sciences Research · doi:10.2991/978-94-6463-190-6_5 · Cited by 1
Asymptomatic Malaria among Pregnant Women Attending Ante-Natal Clinic in Osogbo, Nigeria
A., A. R., Adeagbo, I. A., Igbe, E. U., Uthman-Izobo, O. S., & Akindele, A. A. (2023) · Pan African Journal of Life Sciences · doi:10.36108/pajols/3202/70.0370
Doenças Infecciosas e Parasitárias - Edição XIII
Freitas, G. B. L. D., Gabriel, G. R., CRISCUOLO, G. B., CARVALHO, C. G. D., Passos, T. K. D. C., Felicio, M. V. R. L. M., Castro, A. A. D. N., STEINACHER, F. M., Gerlach, M. P. P., COELHO, C. P., et al. (2024) · doi:10.59290/978-65-6029-142-3
AVALIAÇÃO DE TECNOLOGIA EM SAÚDE NO CONTEXTO DAS DOENÇAS INFECCIOSAS
da Costa, C. M. M., Costa, L. P. D. S., & Carneiro, S. R. (2025) · Editora Pascal LTDA eBooks · doi:10.29327/5550905.1-1
Lema, G. D., Dagnaw, A. B., & Gebeyaw, E. D. (2025) · Case Reports in Medicine · doi:10.1155/carm/1035584
“In some cases, it can cause placental malaria, which afects fetal nutrition and growth [4, 16, 25, 27, 43, 44].”
Aung, P. P., Han, K. T., Groot, W. N. J., Biesma, R., Thein, Z. W., Htay, T., Lin, Z., Aye, K. H., Adams, M., & Pavlova, M. (2024) · Figshare · doi:10.6084/m9.figshare.25374717
Aung, P. P., Han, K. T., Groot, W. N. J., Biesma, R., Thein, Z. W., Htay, T., Lin, Z., Aye, K. H., Adams, M., & Pavlova, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690692
Aung, P. P., Han, K. T., Groot, W. N. J., Biesma, R., Thein, Z. W., Htay, T., Lin, Z., Aye, K. H., Adams, M., & Pavlova, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690686
Seijas-Chávez, J. A., Nolan, M. S., Lynn, M. K., da Rocha, M. J. F., da Costa Araújo, M., Fonseca, F. L. A., & Laporta, G. Z. (2021) · Figshare · doi:10.6084/m9.figshare.17083757
Aung, P. P., Han, K. T., Groot, W. N. J., Biesma, R., Thein, Z. W., Htay, T., Lin, Z., Aye, K. H., Adams, M., & Pavlova, M. (2024) · Figshare · doi:10.6084/m9.figshare.25374840
Aung, P. P., Han, K. T., Groot, W. N. J., Biesma, R., Thein, Z. W., Htay, T., Lin, Z., Aye, K. H., Adams, M., & Pavlova, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690689
Seijas-Chávez, J. A., Nolan, M. S., Lynn, M. K., da Rocha, M. J. F., da Costa Araújo, M., Fonseca, F. L. A., & Laporta, G. Z. (2021) · Figshare · doi:10.6084/m9.figshare.17083751
Duque-Isaza, Y. Y., Carmona‐Fonseca, J., & Arango, E. (2025) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2025.424.14865
Ziliotto, M., Ellwanger, J. H., Dombrowski, J. G., Marinho, C. R. F., Pontillo, A., & Chies, J. A. B. (2025) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2025-0056
“Additional data on clinical, immunological and demographic characteristics of these women were detailed in previous studies (Dombrowski et al. , 2019; Dombrowski et al. , 2021).”
Self-citationTovar, C., Aparicio, P., & Tovar-Falón, R. (2026) · IJID Regions · doi:10.1016/j.ijregi.2026.100974
“Although the mechanisms underlying these associations are not fully understood, they likely involve a combination of maternal anemia, systemic inflammation, recurrent malaria episodes, and placental alterations that may compromise oxygen and nutrient exchange within the maternal–fetal unit [ 7 ].”
Vous Pouvez Télécharger Tout le Numéro en Cliquant Ici
Amvene, S. N. (2024) · HEALTH SCIENCES AND DISEASE · doi:10.5281/hsd.v25i10.6199
Camara, H. F., Diakité, D., Sow, A., Tounkara, A. F., Kourouma, M., & Sidibé, S. (2024) · HEALTH SCIENCES AND DISEASE · doi:10.5281/hsd.v25i10.6106 · Cited by 1
Metadata
- Authors
- Dombrowski, J. G., Barateiro, A., Peixoto, E. P. M., Barros, A. B. C. D. S., Souza, R. M. D., Clark, T. G., Campino, S., Wrenger, C., Wunderlich, G., Palmisano, G., Epiphanio, S., Gonçalves, L. A., & Marinho, C. R. F.
- Affiliations
- Universidade de São Paulo (BR)
- Instituto Gulbenkian de Ciência (PT)
- Universidade Federal do Acre (BR)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Dombrowski, Jamille Gregório
- Barateiro, André
- Peixoto, Erika Paula Machado
- Barros, André Boler Cláudio da Silva
- Souza, Rodrigo Medeiros de
- Clark, Taane Gregory
- Campino, Susana
- Wrenger, Carsten
- Wunderlich, Gerhard
- Palmisano, Giuseppe
- Gonçalves, Lígia Antunes
- ORCID
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-29
- Volume
- 15
- Issue
- 4
- Pages
- e0009390
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- PMC
- PMC8112668
- OpenAlex
- W3158909516
- Cited by
- 42
- References
- 77
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 8 · 2021: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-05-11)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS neglected tropical diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/20468-0; 2020/06747-4, 2017/05782-8, 2015/26722-8; 2017/03966-4, 2017/24267-7, 2018/18257-1; 2018/15549-1; 2020/04923-0, 2019/12068-5, 2017/03939-7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (409216/2018-6)
- Medical Research Council United Kingdom (MR/M01360X/1; MR/N010469/1; MR/R025576/1; MR/R020973/1, MR/M01360X/1; MR/R025576/1; MR/R020973/1)
- Fundação para a Ciência e a Tecnologia (PD/BD/138900/2018)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- Plasmodium vivax, malaria in pregnancy, adverse pregnancy outcomes, preterm birth, fetal head circumference, placental pathology, angiopoietin-2, C5a, angiogenic imbalance, first trimester, maternal and fetal health, Brazilian Amazon
- MeSH terms
- Adolescent, Adult, Antigens, Protozoan, Brazil, Female, Humans, Immunoglobulin G, Infant, Newborn, Placenta, Plasmodium vivax, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Pregnancy Trimester, First, Prospective Studies, Multivariate Analysis, Logistic Models, Malaria, Falciparum, Malaria, Vivax, Premature Birth, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.